Member Login

Username:       Password:

 Remember me Lost your password?

Not a member yet? Sign Up!

Organization:
Email:

I agree to the terms and conditions
Search
Refine
  • Associated Entities
  • Broad Categories
  • Journals
  • Author
  • View All






Webinar



Understanding multiple target preferences for Drug Re - purposing & therapeutic Switching in Cancer Therapies


more....







The only Semantic discovery and Expert annotated Knowledgebase platform updated with "manually" annotated facts from PubMed on a regular basis.


Access Now







XTractor Alerts enables in managing searches and storing the most significant information tagged in a personalized profile.


Access Now




Help X
  • Protein
  • Disease
  • Drug
  • Process
? x
Journals



Author



Affiliation



Publications



Associated Entities



Symbol:
Methamphetamine
Alias:
Methamphetamine; (+ )-methylamphetamine; (+)-(s)-deoxyephedrine; (+)-(s)-n-alpha-dimethylphenethylamine; (+)-2-(N-Methylamino)-1-phenylpropane; (+)-methamphetamine; (+)-methylamphetamine; (+)-n,alpha-dimethyl-beta-phenylethylamine; (+)-n,alpha-dimethylphenethylamine; (+)-n-methylamphetamine; (2S)-N-methyl-1-phenylpropan-2-amine; (s)-(+)-deoxyephedrine; (s)-(+)-methamphetamine; (s)-(+)-n,alpha,dimethylphenethylamine; (s)-methamphetamine; (s)-methylamphetamine; (s)-n,alpha-dimethylbenzeneethanamine; (s)-n,alpha-dimethylbenzeneethanoamine; 1-Phenyl-2-methylamino-propan [German]; 1-Phenyl-2-methylaminopropane; 2S-(+)-Methamphetamine; D-(s)-methamphetamine; D-1-Phenyl-2-methylaminopropane; D-deoxyephedrine; D-desoxyephedrine; D-methamphetamine; D-methylamphetamine; D-n,alpha-dimethylphenethylamine; D-n-methylamphetamine; D-phenylisopropylmethylamine; Desoxyephedrine hydrochloride; L-methamphetamine; Metamfetamina [inn-spanish]; Metamfetaminum [inn-latin]; Metamphetamine; Metanfetamina [inn-spanish]; Methamphetaminum [inn-latin]; Methyl-beta-phenylisopropylamine; Methylamphetamine; N-Methyl-1-phenyl-2-propanamine; N-methyl-beta-phenylisopropylamin [german]; N-methyl-beta-phenylisopropylamine; N-methylamphetamine; S-(+)-methamphetamine; d-1-Phenyl-2-methylaminopropan [German]

Result For Methamphetamine

Total References : 5746
  • Year: 
  •  
References for year 2010: 107
  • 10
  • 20
  • 50
Evidence of Methamphetamine Exposure in Children Removed From Clandestine Methamphetamine Laboratories.
PMID:20042914
Author: Grant P, Bell K, Stewart D, Paulson J, Rogers K
Journal: Pediatr Emerg Care
Affiliation: From the *Montefiore Medical Center, Bronx, New York, daggerAlbert Einstein College of Medicine, Bronx, NY; double daggerTulsa Police Department, Tulsa, OK; section signDepartment of Pediatrics, Children's Hospital, University of California, Davis, CA; and parallelCox Family Medicine Residency, Springfield, MO.
OBJECTIVE:: To determine whether asymptomatic children removed from clandestine methamphetamine laboratories have evidence of exposure to methamphetamine. METHODS:: Retrospective chart review of children removed from law enforcement-certified clandestine methamphetamine laboratories in the Tulsa area of Oklahoma and Sacramento County, California. more...
OBJECTIVE:: To determine whether asymptomatic children removed from clandestine methamphetamine laboratories have evidence of exposure to methamphetamine. METHODS:: Retrospective chart review of children removed from law enforcement-certified clandestine methamphetamine laboratories in the Tulsa area of Oklahoma and Sacramento County, California. Exposure was determined by positive urine toxicology for methamphetamine. RESULTS:: One hundred four children were evaluated after removal from clandestine methamphetamine laboratories. Forty-eight children (46%) tested positive for methamphetamine. Timed urine results were known for 68 of 104, with no child testing positive after 6.5 hours from being removed from the laboratory. No child required emergency medical treatment at the time urine samples were obtained. CONCLUSIONS:: Almost half of the children in this sample had evidence of exposure to methamphetamine soon after removal from methamphetamine manufacturing environments. Further research is indicated to determine the health effects of subclinical methamphetamine exposure. less...
GeneDiseaseDrugProcessesCategories
  • Methamphetamine

Neurochemical Alterations in Methamphetamine-Dependent Patients Treated with Cytidine-5'-Diphosphate Choline: A Longitudinal Proton Magnetic Resonance Spectroscopy Study.
PMID:20043005
Author: Yoon SJ, Lyoo IK, Kim HJ, Kim TS, Sung YH, Kim N, Lukas SE, Renshaw PF
Journal: Neuropsychopharmacology
Affiliation: Department of Psychiatry, Catholic University of Korea School of Medicine, Seoul, South Korea.
Cytidine-5'-diphosphate choline (CDP-choline), as an important intermediate for major membrane phospholipids, may exert neuroprotective effects in various neurodegenerative disorders. This longitudinal proton magnetic resonance spectroscopy ((1)H-MRS) study aimed to examine whether a 4-week CDP-choline treatment could alter neurometabolite levels in patients with methamphetamine (MA) dependence and to investigate whether changes in neurometabolite levels would be associated with MA use. more...
Cytidine-5'-diphosphate choline (CDP-choline), as an important intermediate for major membrane phospholipids, may exert neuroprotective effects in various neurodegenerative disorders. This longitudinal proton magnetic resonance spectroscopy ((1)H-MRS) study aimed to examine whether a 4-week CDP-choline treatment could alter neurometabolite levels in patients with methamphetamine (MA) dependence and to investigate whether changes in neurometabolite levels would be associated with MA use. We hypothesized that the prefrontal levels of N-acetyl-aspartate (NAA), a neuronal marker, and choline-containing compound (Cho), which are related to membrane turnover, would increase with CDP-choline treatment in MA-dependent patients. We further hypothesized that this increase would correlate with the total number of negative urine results. Thirty-one treatment seekers with MA dependence were randomly assigned to receive CDP-choline (n=16) or placebo (n=15) for 4 weeks. Prefrontal NAA and Cho levels were examined using (1)H-MRS before medication, and at 2 and 4 weeks after treatment. Generalized estimating equation regression analyses showed that the rate of change in prefrontal NAA (p=0.005) and Cho (p=0.03) levels were greater with CDP-choline treatment than with placebo. In the CDP-choline-treated patients, changes in prefrontal NAA levels were positively associated with the total number of negative urine results (p=0.03). Changes in the prefrontal Cho levels, however, were not associated with the total number of negative urine results. These preliminary findings suggest that CDP-choline treatment may exert potential neuroprotective effects directly or indirectly because of reductions in drug use by the MA-dependent patients. Further studies with a larger sample size of MA-dependent patients are warranted to confirm a long-term efficacy of CDP-choline in neuroprotection and abstinence.Neuropsychopharmacology advance online publication, 30 December 2009; doi:10.1038/npp.2009.221. less...
GeneDiseaseDrugProcessesCategories
  • COLI_HUMAN
  • Neurodegenerative Diseases
  • Methamphetamine
  • Choline
  • neuroprotection
  • Drug based Studies
  • Protein/Gene relationships
Neurochemical Alterations in Methamphetamine-Dependent Patients Treated with Cytidine-5'-Diphosphate Choline: A Longitudinal Proton Magnetic Resonance Spectroscopy Study.
GeneDiseaseDrugProcessesCategories
  • Methamphetamine
  • Choline
  • Drug based Studies
Cytidine-5'-diphosphate choline (CDP-choline), as an important intermediate for major membrane phospholipids, may exert neuroprotective effects in various neurodegenerative disorders.
GeneDiseaseDrugProcessesCategories
  • Neurodegenerative Diseases
  • Choline
  • Drug based Studies
This longitudinal proton magnetic resonance spectroscopy ((1)H-MRS) study aimed to examine whether a 4-week CDP-choline treatment could alter neurometabolite levels in patients with methamphetamine (MA) dependence and to investigate whether changes in neurometabolite levels would be associated with MA use.
GeneDiseaseDrugProcessesCategories
  • Methamphetamine
  • Choline
  • Drug based Studies
Further studies with a larger sample size of MA-dependent patients are warranted to confirm a long-term efficacy of CDP-choline in neuroprotection and abstinence.Neuropsychopharmacology advance online publication, 30 December 2009; doi:10.1038/npp.2009.221.
GeneDiseaseDrugProcessesCategories
  • COLI_HUMAN
  • Choline
  • neuroprotection
  • Drug based Studies
  • Protein/Gene relationships

Methamphetamine acts on subpopulations of neurons regulating sexual behavior in male rats.
PMID:20045448
Author: Frohmader KS, Wiskerke J, Wise RA, Lehman MN, Coolen LM
Journal: Neuroscience
Affiliation: Department of Anatomy & Cell Biology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada, N6A 5C1.
Methamphetamine (Meth) is a highly addictive stimulant. Meth abuse is commonly associated with the practice of sexual risk behavior and increased prevalence of Human Immunodeficiency Virus and Meth users report heightened sexual desire, arousal, and sexual pleasure. more...
Methamphetamine (Meth) is a highly addictive stimulant. Meth abuse is commonly associated with the practice of sexual risk behavior and increased prevalence of Human Immunodeficiency Virus and Meth users report heightened sexual desire, arousal, and sexual pleasure. The biological basis for this drug-sex nexus is unknown. The current study demonstrates that Meth administration in male rats activates neurons in brain regions of the mesolimbic system that are involved in the regulation of sexual behavior. Specifically, Meth and mating co-activate cells in the nucleus accumbens core and shell, basolateral amygdala, and anterior cingulate cortex. These findings illustrate that in contrast to current belief drugs of abuse can activate the same cells as a natural reinforcer, i.e. sexual behavior, and in turn may influence compulsive seeking of this natural reward. less...
GeneDiseaseDrugProcessesCategories
  • Methamphetamine
  • mating

Dysfunction of dopamine release in the prefrontal cortex of dysbindin deficient sandy mice: an in vivo microdialysis study.
PMID:20045719
Author: Nagai T, Kitahara Y, Shiraki A, Hikita T, Taya S, Kaibuchi K, Yamada K
Journal: Neurosci Lett
Affiliation: Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine, 65 Tsuruma-cho, Showa-ku, Nagoya 466-8560, Japan.
Dystrobrevin binding protein-1 gene (DTNBP1), which encodes dysbindin protein, has been identified as a schizophrenia susceptibility gene. Dysbindin has been shown to contribute to the regulation of exocytosis and formation of synaptic vesicles. more...
Dystrobrevin binding protein-1 gene (DTNBP1), which encodes dysbindin protein, has been identified as a schizophrenia susceptibility gene. Dysbindin has been shown to contribute to the regulation of exocytosis and formation of synaptic vesicles. Although hypofrontality in schizophrenia underlies its pathophysiology, the molecular function of dysbindin in synaptic neurotransmission remains unclear. In the present study, we investigated depolarization-evoked dopamine (DA) and serotonin (5-HT) release in the prefrontal cortex (PFC) of sandy (sdy) mice, which have a deletion mutation in the gene encoding DTNBP1. In vivo microdialysis analysis revealed that extracellular DA levels in the PFC of wild-type mice were increased by 60mM KCl stimulation, and the KCl-evoked DA release was significantly decreased in sdy mice compared with wild-type mice. Extracellular 5-HT levels in the PFC of wild-type mice were also increased by 60mM KCl stimulation. The KCl-evoked 5-HT release did not differ between wild-type and sdy mice. There was no difference in basal levels of DA and 5-HT before the stimulation between two groups. Behavioral sensitization after repeated methamphetamine (METH) treatment was significantly reduced in sdy mice compared with wild-type mice whereas no difference was observed in METH-induced hyperlocomotion between two groups. These results suggest that dysbindin may have a role in the regulation of depolarization-evoked DA release in the PFC and in the development of behavioral sensitization induced by repeated METH treatment. less...
GeneDiseaseDrugProcessesCategories
  • DTBP1_HUMAN
  • Schizophrenia
  • Methamphetamine
  • regulation of exocytosis
  • Protein/Gene relationships
  • Protein/Gene Functional studies
Dystrobrevin binding protein-1 gene (DTNBP1), which encodes dysbindin protein, has been identified as a schizophrenia susceptibility gene.
GeneDiseaseDrugProcessesCategories
  • DTBP1_HUMAN
  • Schizophrenia
  • Protein/Gene relationships
Dysbindin has been shown to contribute to the regulation of exocytosis and formation of synaptic vesicles.
GeneDiseaseDrugProcessesCategories
  • DTBP1_HUMAN
  • regulation of exocytosis
  • Protein/Gene relationships
Although hypofrontality in schizophrenia underlies its pathophysiology, the molecular function of dysbindin in synaptic neurotransmission remains unclear.
GeneDiseaseDrugProcessesCategories
  • DTBP1_HUMAN
  • Schizophrenia
  • Protein/Gene relationships
In the present study, we investigated depolarization-evoked dopamine (DA) and serotonin (5-HT) release in the prefrontal cortex (PFC) of sandy (sdy) mice, which have a deletion mutation in the gene encoding DTNBP1.
GeneDiseaseDrugProcessesCategories
  • DTBP1_HUMAN
  • Protein/Gene Functional studies
Behavioral sensitization after repeated methamphetamine (METH) treatment was significantly reduced in sdy mice compared with wild-type mice whereas no difference was observed in METH-induced hyperlocomotion between two groups.
GeneDiseaseDrugProcessesCategories
  • DTBP1_HUMAN
  • Methamphetamine
  • Protein/Gene relationships

Wound botulism in injection drug users: time to antitoxin correlates with intensive care unit length of stay.
PMID:20046244
Author: Offerman SR, Schaefer M, Thundiyil JG, Cook MD, Holmes JF
Journal: West J Emerg Med
Affiliation: Kaiser Permanente South Sacramento Medical Center, Department of Emergency Medicine, Sacramento, CA.
OBJECTIVES: We sought to identify factors associated with need for mechanical ventilation (MV), length of intensive care unit (ICU) stay, length of hospital stay, and poor outcome in injection drug users (IDUs) with wound botulism (WB). METHODS: This is a retrospective review of WB patients admitted between 1991-2005. more...
OBJECTIVES: We sought to identify factors associated with need for mechanical ventilation (MV), length of intensive care unit (ICU) stay, length of hospital stay, and poor outcome in injection drug users (IDUs) with wound botulism (WB). METHODS: This is a retrospective review of WB patients admitted between 1991-2005. IDUs were included if they had symptoms of WB and diagnostic confirmation. Primary outcome variables were the need for MV, length of ICU stay, length of hospital stay, hospital-related complications, and death. RESULTS: Twenty-nine patients met inclusion criteria. Twenty-two (76%) admitted to heroin use only and seven (24%) admitted to heroin and methamphetamine use. Chief complaints on initial presentation included visual changes, 13 (45%); weakness, nine (31%); and difficulty swallowing, seven (24%). Skin wounds were documented in 22 (76%). Twenty-one (72%) patients underwent mechanical ventilation (MV). Antitoxin (AT) was administered to 26 (90%) patients but only two received antitoxin in the emergency department (ED). The time from ED presentation to AT administration was associated with increased length of ICU stay (Regression coefficient = 2.5; 95% CI 0.45, 4.5). The time from ED presentation to wound drainage was also associated with increased length of ICU stay (Regression coefficient = 13.7; 95% CI = 2.3, 25.2). There was no relationship between time to antibiotic administration and length of ICU stay. CONCLUSION: MV and prolonged ICU stays are common in patients identified with WB. Early AT administration and wound drainage are recommended as these measures may decrease ICU length of stay. less...
GeneDiseaseDrugProcessesCategories
  • Botulism
  • Methamphetamine
  • Heroin
  • Drug based Studies
Twenty-two (76%) admitted to heroin use only and seven (24%) admitted to heroin and methamphetamine use.
GeneDiseaseDrugProcessesCategories
  • Methamphetamine
  • Heroin
  • Drug based Studies

Spontaneous multivessel coronary artery dissection.
PMID:20048405
Author: Kanwar M, Gill N
Journal: J Invasive Cardiol
Affiliation: St. John Hospital and Medical Center, 22101 Moross Road, 2nd Floor VEP, Cardiac Cath Lab, Detroit, MI, 48236, USA. manreet.kanwar@stjohn.org.
As opposed to iatrogenic coronary dissection, spontaneous dissection is an extremely rare clinical condition. Typically seen in a single coronary vessel of peripartum women presenting with acute coronary syndrome, there are isolated case reports of men presenting multivessel involvement for this life-threatening condition. more...
As opposed to iatrogenic coronary dissection, spontaneous dissection is an extremely rare clinical condition. Typically seen in a single coronary vessel of peripartum women presenting with acute coronary syndrome, there are isolated case reports of men presenting multivessel involvement for this life-threatening condition. We describe a 54-year-old male with a history of diabetes, hypertension and methamphetamine abuse who presented to the emergency after a brief, witnessed cardiac arrest. Admission ECG revealed sinus tachycardia with inferior Q waves. He was found to have frequent runs of non-sustained ventricular tachycardia and minimal troponin-T elevation. His 2-D echocardiogram showed apical akinesis with an ejection fraction of 50%. Cardiac catheterization revealed a patent left main artery with a spontaneous dissection involving the mid to distal LAD artery, as well as large first diagonal branch with proximal dissection. His dominant RCA also showed long spontaneous dissection extending from proximal to distal vessel, along with distal focal 90% atherosclerotic lesion. Ramus intermedius and left circumflex vessels were free of disease. The patient underwent a 2-vessel coronary artery bypass grafting (CABG) with excellent outcome. Although cocaine abuse has been known to be associated with spontaneous dissection, this is the first reported case of a methamphetamine user presenting with multivessel coronary dissection. less...
GeneDiseaseDrugProcessesCategories
  • ITB2_HUMAN
  • Heart Arrest
  • Hypertension
  • Tachycardia, Sinus
  • Tachycardia, Ventricular
  • Cocaine-Related Disorders
  • Acute Coronary Syndrome
  • Methamphetamine
  • Cocaine
  • Disease Mechanisms
  • Drug based Studies
We describe a 54-year-old male with a history of diabetes, hypertension and methamphetamine abuse who presented to the emergency after a brief, witnessed cardiac arrest.
GeneDiseaseDrugProcessesCategories
  • Heart Arrest
  • Hypertension
  • Methamphetamine
  • Disease Mechanisms
  • Drug based Studies
Although cocaine abuse has been known to be associated with spontaneous dissection, this is the first reported case of a methamphetamine user presenting with multivessel coronary dissection.
GeneDiseaseDrugProcessesCategories
  • Cocaine-Related Disorders
  • Methamphetamine
  • Cocaine
  • Drug based Studies

Assessment of Japanese stimulant control law offenders using the Addiction Severity Index--Japanese version: comparison with patients in treatment settings.
PMID:20049245
Author: Watanabe T, Ogai Y, Koga T, Senoo E, Nakamura K, Mori N, Ikeda K
Journal: Int J Environ Res Public Health
Affiliation: Hamamatsu University School of Medicine, Higashi-ku, Hamamatsu, Japan. takashi_matuki@yahoo.co.jp
The present study assessed problems in Japanese prisoners (inmates) who abused methamphetamine. Fifty-two male inmates were assessed in 2005-2007 using the Addiction Severity Index-Japanese version and compared with 55 male methamphetamine abusers in hospitals and recovery centers. more...
The present study assessed problems in Japanese prisoners (inmates) who abused methamphetamine. Fifty-two male inmates were assessed in 2005-2007 using the Addiction Severity Index-Japanese version and compared with 55 male methamphetamine abusers in hospitals and recovery centers. The chi(2) and Mann-Whitney-Wilcoxon tests showed that the inmates had a significantly lower education level, more frequently had full-time jobs, had more experience living with a sexual partner, and more frequently had a history of juvenile delinquency and criminal records than patients. Although psychiatric symptoms, such as depression, anxiety, and hallucinations, were not common among inmates, suicidal behavior and trouble controlling violence were common in both groups. less...
GeneDiseaseDrugProcessesCategories
  • Hallucinations
  • Methamphetamine

Hepatitis Vaccination of Men Who Have Sex with Men at Gay Pride Events.
PMID:20049541
Author: Storholm ED, Fisher DG, Reynolds GL, Napper LE, Morrisse TA, Kochems LM
Journal: Prev Sci
Affiliation: Center for Health, Identity, Behavior & Prevention Studies, New York University, New York, NY, USA.
Prevention researchers have advocated primary prevention such as vaccination in alternative venues. However, there have been major questions about both the attendance of, and the ability to, vaccinate high-risk individuals in such settings. more...
Prevention researchers have advocated primary prevention such as vaccination in alternative venues. However, there have been major questions about both the attendance of, and the ability to, vaccinate high-risk individuals in such settings. The current study seeks to assess the feasibility of vaccinating high-risk men who have sex with men (MSM) at Gay Pride events. The research questions are: Do gay men who are sampled at Gay Pride events engage in more or less risky behavior than gay men sampled at other venues? Do the gay men who receive hepatitis vaccinations at Gay Pride engage in more or less risky behavior than gay men at Gay Pride who do not receive hepatitis vaccination? Of the 3689 MSM that completed the Field Risk Assessment (FRA), 1095/3689 = 29.68% were recruited at either the 2006 or 2007 Long Beach, California Gay Pride events. The remaining, 2594/3689 = 70.32% were recruited at Long Beach gay bars, gay community organizations and institutions, and through street recruitment in various gay enclaves in the Long Beach area. Logistic regression analysis yielded eight factors that were associated with non-attendance of Gay Pride: Age, had sex while high in the last 12 months, had unprotected anal intercourse (UAI) in the last 12 months, had sex for drugs/money in the last 12 months, been diagnosed with a sexually transmitted infection (STI) in the last 12 months, used nitrites (poppers) in the last 12 months, and used methamphetamine in the last 12 months. Identifying as White, Asian, or African American compared to Hispanic was also associated with non-attendance. Bivariate analysis indicated that, of the MSM sampled at Gay Pride, 280/1095 = 25.57% received a hepatitis vaccination there. The MSM sampled at Gay Pride who reported engaging in UAI or having used any stimulant (cocaine, crack-cocaine, or methamphetamine) in the last 12 months were more likely to receive hepatitis vaccination on-site. The results provide evidence for the viability of successfully vaccinating high-risk MSM at Gay Pride events. However, it is vital that no-cost vaccinations are also funded in other community settings such as STI clinics, drug treatment programs, prisons, universities, and other community resource centers in order to reach those additional high-risk MSM who do not attend Gay Pride. less...
GeneDiseaseDrugProcessesCategories
  • Hepatitis
  • Methamphetamine
  • Cocaine
  • Drug based Studies
The MSM sampled at Gay Pride who reported engaging in UAI or having used any stimulant (cocaine, crack-cocaine, or methamphetamine) in the last 12 months were more likely to receive hepatitis vaccination on-site.
GeneDiseaseDrugProcessesCategories
  • Hepatitis
  • Methamphetamine
  • Cocaine
  • Drug based Studies

The protective effect of melatonin on methamphetamine-induced calpain-dependent death pathway in human neuroblastoma SH-SY5Y cultured cells.
PMID:20050990
Author: Suwanjang W, Phansuwan-Pujito P, Govitrapong P, Chetsawang B
Journal: J Pineal Res
Affiliation: Neuro-Behavioural Biology Center, Institute of Molecular Biosciences, Mahidol University, Salaya, Nakornpathom, Thailand.
Methamphetamine (METH) is a potent psychostimulant drug that may cause neuronal cell degeneration. The underlying mechanisms of METH-induced neuronal toxicity remains poorly understood. more...
Methamphetamine (METH) is a potent psychostimulant drug that may cause neuronal cell degeneration. The underlying mechanisms of METH-induced neuronal toxicity remains poorly understood. In this study, we investigated an important role of calpain-dependent cascades in methamphetamine-induced toxicity in human dopaminergic neuroblastoma SH-SY5Y cultured cell lines. In addition, the protective effect of melatonin against METH-induced calpain-dependent death pathway was also investigated. The results of this study show that METH significantly decreased cell viability and tyrosine hydroxylase phosphorylation in SH-SY5Y cultured cells. Melatonin reversed the toxic effect of METH by inducing cell viability. In addition, melatonin was able to restore the reduction in mitochondrial function and phosphorylation of tyrosine hydroxylase in SH-SY5Y treated cells. An induction of calpain expression and activity but a reduction of calpain inhibitor (calpastatin) protein levels were observed in SH-SY5Y cells treated with METH but these effects were diminished by melatonin. These results implicated calpain-dependent death pathways in the processes of METH-induced toxicity and also indicated that melatonin has the capacity to reverse this toxic effect in SH-SY5Y cultured cells. less...
GeneDiseaseDrugProcessesCategories
  • TY3H_HUMAN
  • ICAL_HUMAN
  • Neuroblastoma
  • Methamphetamine
  • Melatonin
  • phosphorylation
  • Protein/Gene Functional studies
  • Protein/Gene relationships
  • Drug based Studies
The protective effect of melatonin on methamphetamine-induced calpain-dependent death pathway in human neuroblastoma SH-SY5Y cultured cells.
GeneDiseaseDrugProcessesCategories
  • TY3H_HUMAN
  • Neuroblastoma
  • Methamphetamine
  • Melatonin
  • Protein/Gene Functional studies
  • Protein/Gene relationships
In this study, we investigated an important role of calpain-dependent cascades in methamphetamine-induced toxicity in human dopaminergic neuroblastoma SH-SY5Y cultured cell lines.
GeneDiseaseDrugProcessesCategories
  • Neuroblastoma
  • Methamphetamine
  • Drug based Studies
The results of this study show that METH significantly decreased cell viability and tyrosine hydroxylase phosphorylation in SH-SY5Y cultured cells.
GeneDiseaseDrugProcessesCategories
  • TY3H_HUMAN
  • phosphorylation
  • Protein/Gene relationships
Melatonin reversed the toxic effect of METH by inducing cell viability.
GeneDiseaseDrugProcessesCategories
  • Melatonin
  • Drug based Studies
In addition, melatonin was able to restore the reduction in mitochondrial function and phosphorylation of tyrosine hydroxylase in SH-SY5Y treated cells.
GeneDiseaseDrugProcessesCategories
  • TY3H_HUMAN
  • Melatonin
  • phosphorylation
  • Protein/Gene relationships
  • Drug based Studies
An induction of calpain expression and activity but a reduction of calpain inhibitor (calpastatin) protein levels were observed in SH-SY5Y cells treated with METH but these effects were diminished by melatonin.
GeneDiseaseDrugProcessesCategories
  • ICAL_HUMAN
  • Melatonin
  • Protein/Gene relationships
These results implicated calpain-dependent death pathways in the processes of METH-induced toxicity and also indicated that melatonin has the capacity to reverse this toxic effect in SH-SY5Y cultured cells.
GeneDiseaseDrugProcessesCategories
  • Melatonin
  • Drug based Studies

Electrochemical oxidation of amphetamine-like drugs and application to electroanalysis of ecstasy in human serum.
PMID:20051327
Author: Garrido EM, Garrido JM, Milhazes N, Borges F, Oliveira-Brett AM
Journal: Bioelectrochemistry
Affiliation: Departamento de Engenharia Química, Instituto Superior de Engenharia do Porto, IPP, 4200-072 Porto, Portugal.
Amphetamine and amphetamine-like drugs are popular recreational drugs of abuse because they are powerful stimulants of the central nervous system. Due to a dramatic increase in the abuse of methylenedioxylated derivatives, individually and/or in a mixture, and to the incoherent and contradictory interpretation of the electrochemical data available on this subject, a comprehensive study of the redox properties of amphetamine-like drugs was accomplished. more...
Amphetamine and amphetamine-like drugs are popular recreational drugs of abuse because they are powerful stimulants of the central nervous system. Due to a dramatic increase in the abuse of methylenedioxylated derivatives, individually and/or in a mixture, and to the incoherent and contradictory interpretation of the electrochemical data available on this subject, a comprehensive study of the redox properties of amphetamine-like drugs was accomplished. The oxidative behaviour of amphetamine (A), methamphetamine (MA), methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) was studied in different buffer systems by cyclic, differential pulse and square-wave voltammetry using a glassy carbon electrode. A quantitative electroanalytical method was developed and successfully applied to the determination of MDMA in seized samples and in human serum. Validation parameters, such as sensitivity, precision and accuracy, were evaluated. The results found using the developed electroanalytical methodology enabled to gather some information about the content and amount of MDMA present in ecstasy tablets found in Portugal. Moreover, the data found in this study outlook the possibility of using the voltammetric methods to investigate the potential harmful effects of interaction between drugs such as MDMA and methamphetamine and other substances often used together in ecstasy tablets. less...
GeneDiseaseDrugProcessesCategories
  • Amphetamine
  • 3,4-Methylenedioxymethamphetamine
  • Methamphetamine
  • Drug based Studies
Electrochemical oxidation of amphetamine-like drugs and application to electroanalysis of ecstasy in human serum.
GeneDiseaseDrugProcessesCategories
  • Amphetamine
  • 3,4-Methylenedioxymethamphetamine
  • Drug based Studies
The oxidative behaviour of amphetamine (A), methamphetamine (MA), methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) was studied in different buffer systems by cyclic, differential pulse and square-wave voltammetry using a glassy carbon electrode.
GeneDiseaseDrugProcessesCategories
  • Amphetamine
  • 3,4-Methylenedioxymethamphetamine
  • Methamphetamine
  • Drug based Studies
Moreover, the data found in this study outlook the possibility of using the voltammetric methods to investigate the potential harmful effects of interaction between drugs such as MDMA and methamphetamine and other substances often used together in ecstasy tablets.
GeneDiseaseDrugProcessesCategories
  • 3,4-Methylenedioxymethamphetamine
  • Methamphetamine
  • Drug based Studies